The puzzling pathogenesis behind COVID-19 has thrown up many clinical dilemmas for physicians across the globe, including cardiologists. The rapid accumulation of evidence indicates the presence of a hypercoagulable state in patients with severe COVID-19 which in turn increases the risk of thromboembolic complications. Join us and a leading panel of experts, including Professor Beverley ...
COVID-19 and its implications for thrombosis and anticoagulation
26 May 2020